Form 8-K - Current report:
SEC Accession No. 0001437749-24-018934
Filing Date
2024-05-31
Accepted
2024-05-31 17:10:26
Documents
16
Period of Report
2024-05-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cont20240524_8k.htm   iXBRL 8-K 40154
2 EXHIBIT 10.1 CONTINEUM THERAPEUTICS, INC. EXECUTIVE SEVERANCE PLAN. ex_681655.htm EX-10.1 84649
3 EXHIBIT 10.2 FORM OF REGISTRANT'S MUTUAL ARBITRATION AGREEMENT ex_681656.htm EX-10.2 22080
  Complete submission text file 0001437749-24-018934.txt   311375

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA noticker-20240524.xsd EX-101.SCH 3441
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE noticker-20240524_def.xml EX-101.DEF 11816
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE noticker-20240524_lab.xml EX-101.LAB 15848
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE noticker-20240524_pre.xml EX-101.PRE 12031
19 EXTRACTED XBRL INSTANCE DOCUMENT cont20240524_8k_htm.xml XML 2969
Mailing Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Filer) CIK: 0001855175 (see all company filings)

EIN.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42001 | Film No.: 241010779
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)